Interim data from a trial for UCB’s investigational IL-17A and IL-17F inhibitor bimekizumab in adults with moderate to severe plaque psoriasis have been presented during a presentation at the 2021 American Academy of Dermatology (AAD) summer meeting ...
As the Memorial Day weekend begins, many Americans are confused about the proper application of sunscreen and about its sun protection factor (SPF), the American Academy of Dermatology (AAD) says.
Obesity may cause a differential response to antiarrhythmic drugs (AADs) used to suppress atrial fibrillation (AF), according to a study published online in JAMA Cardiology.